[Federal Register Volume 89, Number 58 (Monday, March 25, 2024)]
[Notices]
[Pages 20697-20698]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-06185]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1342]


Bulk Manufacturer of Controlled Substances Application: Purisys, 
LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Purisys, LLC has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
May 24, 2024. Such persons may also file a written request for a 
hearing on the application on or before May 24, 2024.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on February 8, 2024, Purisys, LLC, 1550 Olympic Drive, 
Athens, Georgia 30601-1602, applied to be registered as a bulk 
manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
            Controlled substance               Drug code     Schedule
------------------------------------------------------------------------
Cathinone...................................        1235  I
Gamma Hydroxybutyric Acid...................        2010  I
Ibogaine....................................        7260  I
Lysergic acid diethylamide..................        7315  I
Marihuana Extract...........................        7350  I
Marihuana...................................        7360  I
Tetrahydrocannabinols.......................        7370  I
Mescaline...................................        7381  I
2,5-Dimethoxyamphetamine....................        7396  I
3,4-Methylenedioxyamphetamine...............        7400  I
3,4-Methylenedioxy-N-ethylamphetamine.......        7404  I
3,4-Methylenedioxymethamphetamine...........        7405  I
5-Methoxy-N,N-dimethyltryptamine............        7431  I
Diethyltryptamine...........................        7434  I
Dimethyltryptamine..........................        7435  I
Psilocybin..................................        7437  I
Psilocyn....................................        7438  I
5-Methyoxy-N,N-diisopropyltryptamine........        7439  I
Methylone (3,4-Methylenedioxy-N-                    7540  I
 methylcathinone).
Codeine-N-oxide.............................        9053  I
Dihydromorphine.............................        9145  I
Heroin......................................        9200  I

[[Page 20698]]

 
Hydromorphinol..............................        9301  I
Morphine-N-oxide............................        9307  I
Normorphine.................................        9313  I
Norlevorphanol..............................        9634  I
Amphetamine.................................        1100  II
Lisdexamfetamine............................        1205  II
Methylphenidate.............................        1724  II
Pentobarbital...............................        2270  II
Nabilone....................................        7379  II
Cocaine.....................................        9041  II
Codeine.....................................        9050  II
Dihydrocodeine..............................        9120  II
Oxycodone...................................        9143  II
Hydromorphone...............................        9150  II
Ecgonine....................................        9180  II
Hydrocodone.................................        9193  II
Levorphanol.................................        9220  II
Meperidine..................................        9230  II
Meperidine intermediate-A...................        9232  II
Meperidine intermediate-B...................        9233  II
Meperidine intermediate-C...................        9234  II
Methadone intermediate......................        9250  II
Methadone intermediate......................        9254  II
Morphine....................................        9300  II
Oripavine...................................        9330  II
Thebaine....................................        9333  II
Opium tincture..............................        9630  II
Opium, powdered.............................        9639  II
Opium, granulated...........................        9640  II
Oxymorphone.................................        9652  II
Noroxymorphone..............................        9668  II
Alfentanil..................................        9737  II
Sufentanil..................................        9740  II
Carfentanil.................................        9743  II
Tapentadol..................................        9780  II
Fentanyl....................................        9801  II
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for the production of active pharmaceutical ingredients 
(API) and analytical reference standards for sale to its customers. The 
company plans to manufacture the above listed controlled substances as 
clinical trial and starting materials to make compounds for 
distribution to its customers. No other activities for these drug codes 
are authorized for this registration.

Marsha Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-06185 Filed 3-22-24; 8:45 am]
BILLING CODE P